Open Access Green as soon as Postprint is submitted to ZB.
The Solve-RD Solvathons as a pan-European interdisciplinary collaboration to diagnose patients with rare disease.
Nat. Genet. 57, 2361-2370 (2025)
Despite advances in genomic diagnostics, the majority of individuals with rare diseases remain without a confirmed genetic diagnosis. The rapid emergence of advanced omics technologies, such as long-read genome sequencing, optical genome mapping and multiomic profiling, has improved diagnostic yield but also substantially increased analytical and interpretational complexity. Addressing this complexity requires systematic multidisciplinary collaboration, as recently demonstrated by targeted diagnostic workshops. Here, we highlight the experience of the Solve-RD consortium, a pan-European initiative, in implementing four structured workshops, termed 'Solvathons', as a regular and effective component of its operational workflow. We provide actionable insights, best practices and lessons learned for successful data integration, expert training and scalable collaborative diagnostics within large research consortia.
Impact Factor
Scopus SNIP
Altmetric
29.000
0.000
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Review
Keywords
Repeat
Language
english
Publication Year
2025
HGF-reported in Year
2025
ISSN (print) / ISBN
1061-4036
e-ISSN
1546-1718
Journal
Nature Genetics
Quellenangaben
Volume: 57,
Issue: 10,
Pages: 2361-2370
Publisher
Nature Publishing Group
Publishing Place
New York, NY
Reviewing status
Peer reviewed
Institute(s)
Institute of Computational Biology (ICB)
POF-Topic(s)
30205 - Bioengineering and Digital Health
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-503800-001
Grants
Predoctoral program 'Joan Oro' of the Secretary of Universities and Research of the Department of Research and Universities of the Government of Catalonia
ERN ITHACA
ERN RND
ERN EURO-NMD
ERN GENTURIS
ERN EpiCARE
ERN RITA
EU
European Union's Horizon Europe research and innovation program
Deutsche Forschungsgemeinschaft (German Research Foundation)
ZonMw (the Netherlands Organisation for Health Research and Development) Vici grant
European Union's Horizon 2020 research and innovation program
ERN ITHACA
ERN RND
ERN EURO-NMD
ERN GENTURIS
ERN EpiCARE
ERN RITA
EU
European Union's Horizon Europe research and innovation program
Deutsche Forschungsgemeinschaft (German Research Foundation)
ZonMw (the Netherlands Organisation for Health Research and Development) Vici grant
European Union's Horizon 2020 research and innovation program
WOS ID
001566734300001
Scopus ID
105016833561
PubMed ID
40926087
Erfassungsdatum
2025-10-20